Drug Type Small molecule drug |
Synonyms AM 112, AM-112, AM112 |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H44O5 |
InChIKeyCKQVRZJOMJRTOY-UHFFFAOYSA-N |
CAS Registry11099-07-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | United Kingdom | 10 May 2003 | |
Gram-Positive Bacterial Infections | Preclinical | United Kingdom | 10 May 2003 | |
Bacterial Infections | Preclinical | United Kingdom | - |